About
SmartCatch develops microfiltration-based medical devices and consumables to isolate circulating tumor cells (CTCs) directly from whole blood for liquid biopsy applications. Its product pipeline includes a benchtop instrument (CTC-Station) for R&D and a portable system (CTC-Pheresis) aimed at clinical routine monitoring and prognosis.
Explore SmartCatch's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.